Midwest Virology Symposium
Welcome to the Midwest Virology Symposium 2025
Thank you for joining us for the 2025 Midwest Virology Symposium (MVS), a three-day gathering of virology researchers, clinicians, and trainees from across the Midwest. Hosted at the University of Kentucky, the symposium brought together participants for keynote presentations, scientific sessions, trainee talks, poster presentations, and networking across institutions and disciplines.
The 2025 symposium was held at the University of Kentucky, with Day 1 hosted in the state-of-the-art Jacobs Science Building and Days 2 and 3 hosted in the Gatton Student Center.
MVS 2025 Organizing Committee
Special thanks to the MVS Organizing Committee for their leadership, collaboration, and work in making the 2025 symposium a success.
Faculty - Saurabh Chattopadhyay, PhD (Medicine) | Rebecca Dutch, PhD (Medicine) | Krystal Kuhs, PhD (Public Health) | Feng Li, PhD (Agriculture, Food and Environment) | Vince Venditto, PhD (Pharmacy)
Trainees - Chase Heim (Medicine), Kripa Giri (Agriculture, Food and Environment)
Registration and Information
Thank You for Joining Us
Thank you to everyone who participated in the Midwest Virology Symposium. We are grateful to the speakers, poster presenters, attendees, sponsors, volunteers, and organizing committee members who helped make the event a success.
Abstract Submission
Abstract submission is now closed. Thank you to all who submitted abstracts and contributed to the scientific program through poster and oral presentations.
Questions?
For questions about the symposium or request for materials, please contact the organizing committee at curekyidc@uky.edu.
Keynote Presentation and Scientific Sessions
Keynote Speaker – Stanley Perlman, MD, PhD
We were honored to welcome Dr. Stanley Perlman, Professor of Microbiology and Immunology at the University of Iowa, as our keynote speaker for the 2025 Midwest Virology Symposium.
Dr. Perlman is a renowned expert in coronavirus biology and host immune responses, with groundbreaking contributions to our understanding of SARS-CoV, MERS-CoV, and SARS-CoV-2. His decades of work have shaped global responses to viral outbreaks and informed major public health strategies. Thank you to Dr. Perlman for participating and delivering an excellent presentation titled, "Neurological PASC in humans and mice."
Scientific Sessions - Day One
Virology and Emerging Threats | Session I
Richard Kuhn, PhD (Purdue University) - Structural studies focused on Alphaviruses and Flaviviruses in Complex with Antibodies
Natasha Tilston-Lunel, PhD (Indiana University) - Bunyavirus Reassortment: Compatibility, Constraint, and Consequence
Jae Jung, PhD (Cleveland Clinic) - Inhibitor Discovery of SARS-CoV-2 Nsp14-Nsp10 Exonuclease
Mike Berg, PhD (Abbott Laboratories) - THE ABBOTT PANDEMIC DEFENSE COALITION: Diagnostic preparedness through pathogen surveillance and discovery
Siyuan Ding, PhD (WashU Medicine) - Molecular Determinants of Rotavirus Host Range
Immunity and Pathogenesis | Session II
Amy Hartman, PhD (University of Pittsburgh) - Factors controlling entry, tropism, and disease outcome in response to Rift Valley fever virus
Jacob Yount, PhD (Ohio State University) - Modeling and Mitigating Cardiac Complications of Influenza Virus Infection
Pranav Danthi, PhD (Indiana University) - Antagonism of the innate immunity by reovirus
Bethany Moore, PhD (University of Michigan) - The role of TLR9 in influenza-MRSA co-infection
Megan Freeman, PhD (University of Pittsburgh) - Enterovirus D68 isolates that circulated in 2022 has altered neurotropism (selected from the abstracts)
Scientific Sessions - Day Two
Models and Therapeutics | Session III
Salvatore Simmini, PhD (StemCell Technologies) - Tissue-derived organoid models for in vitro viral infection and antiviral screening (Virtual)
John Williams, MD (University of Wisconsin) - The Nose Knows: Upper Airway Immunity to Human Metapneumovirus
Kerry Empey, PharmD, PhD (University of Pittsburgh) - Development of an intranasal RSV vaccine for young children
Persistence and Oncology | Session IV
Li Wu, PhD (University of Iowa) - Deciphering the Role of m6A Modifications in HIV-1 Latency and Persistence
Sharmila Nair, PhD (University of Louisville) - Leveraging Zika virus and the immune system to treat GBM
Amanda Panfil, PhD (Ohio State University) - SRPK1 interacts with the HTLV-1 hbz RNA and influences cellular proliferation (selected from the abstracts)
Nathan Ungerleider, PhD (Saint Louis University) - EBV broadly disrupts host microRNA maturation in Burkitt’s lymphoma
Krystle Kuhs, PhD (University of Kentucky) - New methods of early detection for HPV-driven oropharyngeal cancer
Thank You to Our Sponsors
We extend our sincere gratitude to our sponsors for their generous support of the Midwest Virology Symposium 2025. Their commitment makes it possible to bring together researchers, trainees, and collaborators from across the region to share discoveries, foster new connections, and advance the field of infectious disease research. We are proud to partner with organizations that share our vision for innovation, collaboration, and scientific excellence.